AKAli Asghar Kiani

Ali Asghar Kiani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ali Asghar Kiani has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case–control study

    by Nader Davari, Fatemeh Ahmadpour, Ali Asghar Kiani, Mozhgan Azadpour, Zari Tahannejad Asadi

    Objective: In chronic lymphocytic leukemia (CLL), lack of expression or dysregulation of some special miRs disrupts apoptosis of malignant cells; thereby miR expression can enhance cell proliferation, disease progression and decrease patient survival. Results: 30 CLL patients and 20 healthy individuals participated in the study. RNA was extracted to evaluate the expression of miR-125, miR-223, BCL-2 and signal transducer and transcription 3 activator (STAT3) genes; quantitative Real Time- PCR (Q-RT-PCR) was performed. MiR-125a and miR-223 expression decreased in the patients compared to the control group (P-Value:0.001). BCL-2 and STAT3 which are the target genes of these two miRs, showed increased expression, in the patients compared to the control subjects (P-Value: 0.001 and P-Value: 0.64 respectively). A significant reverse relationship was found between miR-125a and BCl-2 expression and WBC count. Significantly, miR-223 expression was associated with smoking in patients (P-Value: 0.007). Also, these miRs may have regulatory effects by controlling white blood cell (WBC) production based on the inverse correlation with WBC count and hemoglobin (Hb) concentration. Finally, miR-223 can be used as a prognostic factor in CLL patients; miR-125a may be useful for evaluating the therapeutic approaches based on the inverse link with BCl-2.


  • New Mutations inAPCGene Among Familial Adenomatous Polyposis (FAP) Patients in Iran

    by Payam Shahnazi Gerdehsang, Najmeh Ranji, Mojtaba Gorji, Safoura Pakizehkar, Ali Asghar Kiani, Saeed Veysi

    Familial adenomatous polyposis (FAP) is a disorder by autosomal dominant inheritance caused by mutations in adenomatous polyposis coli (APC) gene. The aim of this paper was the investigation of a part of exon 15 of the APC gene in FAP patients in several provinces of Iran. Blood sample was obtained from FAP patients. A part of exon 15 of APC gene was amplified by PCR and underwent direct sequencing. Researchers found 23 FAP patients by severe polyposis in colorectal and identified new mutations in the three patients, including c.2910delT (17 year old) and c.3577-3578 delCA (30 and 34 year old) with severe polyposis and a substitution (N862K) in α patients. In this paper, small deletions in APC gene led to produce truncated non-functional APC protein. N862K mutation appears to be important for developing the disease. The results of this paper confirmed that there is a correlation between age of onset and phenotype with the proximity of the mutation to 5ʹ-end of gene.